Both in Surgical Instruments
DexCom vs West Pharmaceutical Services
Over the past year DXCM returned +37.3% and WST returned +45.5%; their daily moves had a correlation of 0.19.
DXCM +37.3% WST +45.5%Growth of $1, one year, split-adjusted
| Metric | DXCM | WST |
|---|---|---|
| Price | $82.97 | $406.99 |
| Market cap | $30.94B | $28.35B |
| Today | −2.11% | −0.22% |
| 1 month | −4.5% | +8.0% |
| 6 months | +39.5% | +31.3% |
| Year to date | +25.0% | +47.9% |
| 1 year | +42.5% | +44.3% |
| Revenue growth (YoY) | +11.2% | +8.7% |
| Gross margin | 64.3% | 39.7% |
| Net margin | 20.5% | 24.5% |
| P/E (TTM) | 31.2× | 44.4× |
| Price / sales | 6.1× | 8.3× |
| Net cash | $574.2M | $261.2M |
| Dividend yield | — | 0.22% |
| Volatility (60d) | 29.4% | 20.3% |
| Short % of float | 4.2% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).